Lake Street Maintains Buy on Tandem Diabetes Care, Raises Price Target to $75
Lake Street Maintains Buy on Tandem Diabetes Care, Raises Price Target to $75
Lake Street維持對Tandem糖尿病護理的買入,將目標股價上調至75美元
Lake Street analyst Brooks O'Neil maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Buy and raises the price target from $60 to $75.
萊克街分析師布魯克斯·奧尼爾維持Tandem Diabetes Care(納斯達克股票代碼:TNDM)的買入並將目標股價從60美元上調至75美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。